Market Overview

From Earlier: Mizuho Securities Downgrades Myriad Genetics, Inc. to Neutral, Lowers PT to $30.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MYGN

DateFirmActionFromTo
Feb 2015Mizuho SecuritiesDowngradesBuyNeutral
Feb 2015Credit SuisseDowngradesNeutralUnderperform
Feb 2015JMP SecuritiesUpgradesMarket PerformMarket Outperform

View More Analyst Ratings for MYGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (MYGN)

Around the Web, We're Loving...

Get Benzinga's Newsletters